Cancer Research UK

Skin cancer cells
#Cancer research #Cancer Research UK #Tumours #University College London

Clearing  ‘immune fog’ could stop lung cancer years before diagnosis 

Scientists funded by Cancer Research UK have discovered a “rising fog” that may cloud the immune system’s ability to detect tumours, potentially helping lung cancer develop years before diagnosis.  The team at University College London (UCL), led by Dr James Reading and Professor Sam Janes, were able… Read More

#News

Cancer cells
#Cancer Research UK #Collaboration #Oncology #ORIC Pharmaceuticals

Cancer Research UK and ORIC partner on CIP2A-targeted therapy

Cancer Research UK has signed an agreement with ORIC Pharmaceuticals to advance ORIC-259, a potential first-in-class CIP2A-targeted therapy, into clinical development.  Under the agreement, Cancer Research UK’s Centre for Drug Development (CDD) will fully fund, sponsor, design and execute a Phase I/II clinical trial of ORIC-259, including… Read More

#Cancer Research #News

Heavy-chain-only antibody
#Antibody #Cancer Research UK #KisoJi Biotechnology #Oncology #Phase I trial

First patient receives novel heavy-chain-only antibody

Cancer Research UK and KisoJi Biotechnology have launched a new Phase I/IIa clinical trial for people with selected TROP2-expressing solid tumours.  The study will evaluate the effectiveness and safety of KisoJi’s lead asset, KJ-103, a naked anti-TROP2 antibody.  TROP2 is a transmembrane glycoprotein involved in… Read More

#Cancer Research #News

Cancer cells
#Cancer Research UK #Clinical trials #Oncology #Peptides

Cancer Research UK leads global trial of rare cancer therapy 

Cancer Research UK is leading a group of partners launching a global Phase II trial into rare adrenal gland cancer.  Biotechnology company Cytovation and the Norwegian Cancer Society (NCS) have joined forces with Cancer Research UK for the trial of people with advanced adrenocortical carcinoma (ACC), a rare and… Read More

#News #Trending News

#AI #ASCO #Cancer Research UK #Clinical trial #Combination therapy #Data science #GLP-1 #Incyte #MHRA #Myeloma #Obesity #Oncology #UK #Ulcerative colitis (UC) #Weight loss

This week in Drug Discovery (15 June – 19 June) 

News round-up for 15 June – 19 June by Bruno Quinney, Content Team at DDW.  This week, results show the new Wegovy pill could help patients lose 17% of their body weight. Elsewhere, advances have been made in both cancer treatment and cancer research.  The top stories:     … Read More

#News

#AI #ALS #Cancer Research Horizons #Cancer Research UK #FDA #Malaria #Mergers and acquisitions #Oncology #Real-time clinical trials #Regulatory #Spinogenix #University of Bath #University of Leeds

DDW Highlights: 12 May 2026

The latest episode of the DDW Highlights Podcast is now available to listen to below. DDW’s Bruno Quinney narrates five key stories of the previous week to keep DDW subscribers up-to-date on the latest industry news. Last week, the FDA advanced an initiative to implement real-time clinical trials. Elsewhere, UCB made… Read More

#Podcasts

#AI #ALS #Cancer Research Horizons #Cancer Research UK #FDA #Malaria #Mergers and acquisitions #Oncology #Real-time clinical trials #Regulatory #Spinogenix #University of Bath #University of Leeds

This week in Drug Discovery (4 – 8 May) 

News round-up for 4 – 8 May by Bruno Quinney, Content Team at DDW.  This week, the FDA has advanced an initiative to implement real-time clinical trials. Elsewhere, UCB has made headlines for through an acquisition and its cancer research venture.  The top stories:    FDA moves… Read More

#News

Modern medical science laboratory
#Cancer Research Horizons #Cancer Research UK #Oncology #UCB

Cancer research alliance to advance ‘life-changing’ therapies 

A global initiative is set to leverage oncology expertise to advance a pipeline of novel cancer therapies.  Biopharmaceutical company UCB has announced a new multi-project alliance with Cancer Research UK and its innovation arm, Cancer Research Horizons.   Under the new partnership, Cancer Research UK’s Centre… Read More

#Cancer Research #News

#Bacteria #Blood cancer #Cancer Research UK #HaemaLogiX #Haematology #Institute of Cancer Research #Myeloma #Neuroscience #NHS #Oncology #Orphan drugs #Parkinson's #Rare diseases #University of Edinburgh

This week in Drug Discovery (16 – 20 March) 

News round-up for 16 – 20 March February by Bruno Quinney, Content Team at DDW.  This week, a pioneering method is being used to make drugs for Parkinson’s disease. Elsewhere, advances have been made in both research and trials for common cancers.  The top stories:    Edinburgh team… Read More

#News

Blood cancer
#Blood cancer #Cancer Research UK #NHS

First patient dosed in ROR1-positive blood cancer treatment 

The first patient has been dosed in a treatment for ROR1-positive blood cancers.  NVG-222 is a bispecific T-cell engager targeting ROR1 and CD3, developed by biotechnology company NovalGen.  The drug is the first therapeutic candidate to use NovalGen’s proprietary AutoRegulation technology, an innovation designed to mitigate excessive… Read More

#Cancer Research #News

#Blood cancer #Cancer Research UK #UK

Cancer Research UK invests £2.5m in blood cancer care 

Cancer Research UK has allocated £2.5 million ($3.4 million) to researchers at the University of York to help transform care for patients diagnosed with blood cancers.  The funding is for the world leading Haematological Malignancy Research Network (HMRN), one of the most comprehensive blood cancer research networks in the… Read More

#Cancer Research #News

#Cancer research #Cancer Research UK #National Cancer Institute

Twelve research teams competing for cancer research grants

Twelve leading research teams from around the world have been shortlisted for Cancer Grand Challenges’ fifth funding round, competing to win up to £20 million ($27 million) each to tackle cancer’s most formidable challenges.  Launched in 2020 by Cancer Research UK and the US National Cancer Institute… Read More

#News

Pancreatic cancer
#Autophagy #Cancer Research UK #KRAS #Oncology #Pancreatic cancer

Autophagy disruption provides clues to cancer development

Scientists have uncovered dementia-like behaviour in pancreas cells at risk of turning into cancer.   The findings provide clues that could help in the treatment and prevention of pancreatic cancer, a difficult-to-treat disease linked to 6,900 deaths in the UK every year.   The research was… Read More

#Cancer Research #News

Trophy
#Awards #Cancer research #Cancer Research Horizons #Cancer Research UK

Cancer Research Horizons rewards innovation and entrepreneurship

Cancer Research Horizons, the innovation arm of Cancer Research UK, announced the winners of its third Innovation and Entrepreneurship Awards during an awards ceremony at Merchant Taylors’ Hall, London. Dr Alessia Errico, Associate Director of Search and Evaluation at Cancer Research Horizons, said: “These remarkable innovators demonstrate the determination and… Read More

#Cancer Research #News

Patient using a mammography machine
#AstraZeneca #Breast cancer #Cancer Research UK #Gene mutation #Oncology

New approach shows promise in aggressive breast cancers

A clinical trial for early-stage breast cancer patients with BRCA gene mutations has reported 100% survival after three years.  In a Phase III trial, Cancer Research UK researchers stopped BRCA-linked breast cancers growing or coming back by giving patients olaparib tablets 48 hours after each chemotherapy dose. … Read More

#Cancer Research #News #Trending News